In clinical trials in patients with type 1 or type 2 diabetes, glargine was shown to be as effective as NPH insulin in lowering HbA1c levels [11,12] and was also associated with significantly fewer episodes of symptomatic and nocturnal hypoglycaemia [13]. This evidence concerns the gene INS and Hypoglycemia.